Identifying Market Opportunities Daily

Each morning before the market opens, we deliver a timely trade idea to our subscribers.

Recent Ideas

Chimerix (CMRX)

Keep an eye on monkeypox stocks, like Chimerix (CMRX). “Epidemiologists, public health officials and doctors now fear the government cannot eliminate the disease in that community, and they’re warning that they are running out of time to stop the virus from spreading...

Target (TGT)

On August 3, we mentioned Walmart (WMT), as it traded around $131.59. This morning, the retailer is up another $4.41 to $17.01 after topping earnings expectations, and sticking with second half estimates. It’s also up on the back to school season. A season that’s also...

Energy Fuels (UUUU)

Uranium stocks like Energy Fuels (UUUU) could be solid long-term bets. Investors are betting that nuclear power could be a big part of our future, as we move away from fossil fuels. In fact, according to the World Nuclear Association, the decarbonization goals of the...

Blink Charging (BLNK)

Along with electric vehicles, there’s also growing demand for EV charging stations. In fact, the charging market could be worth $111.9 billion over the next six years from $17.59 billion in 2021. All as global leaders push for their development. In China, for example,...

Lithium Americas (LAC)

Lithium stocks, like Lithium Americas (LAC) just broke out. In fact, if you take a look at a one-year chart of LAC, you can see it just broke above double top resistance around $27.10. From here, we’d like to see it push closer to $34. With the electric vehicle boom...

Rocket Companies (RKT)

Keep an eye on Rocket Companies (RKT). Even though the company missed on earnings, CEO Jay Farner has been actively buying up the stock. According to Barron’s, “He disclosed in a regulatory filing three large purchases this week: 19,500 shares on Wednesday, 20,200...

SPDR S&P Biotech ETF (XBI)

Investors may want to pay close attention to biotech. Especially with the latest biotech M&A boom. “Asset sales, cash distributions, reverse mergers, M&A and several positive datasets have helped lift Biotech off of once unfathomably low levels and back...

Sponsored Content